Pharmabiz

Care.fi raises $8 million in funding to scale AI-driven healthcare revenue cycle management

Care.fi raises $8 million in funding to scale AI-driven healthcare revenue cycle management: Our Bureau, Bengaluru Wednesday, February 11, 2026, 14:40 Hrs [IST] Care.fi, a healthc ...
Pharmabiz

Whatfix doubles down on healthcare with AI-powered suite to erase the EHR burden and enable clinicians to focus on patient care

Whatfix doubles down on healthcare with AI-powered suite to erase the EHR burden and enable clinicians to focus on patient care: Our Bureau, Bengaluru Wednesday, February 11, 2026 ...
Pharmabiz

Articulus Surgical raises seed funding to drive market rollout of India-built surgical robotics platform

Articulus Surgical raises seed funding to drive market rollout of India-built surgical robotics platform: Our Bureau, Bengaluru Wednesday, February 11, 2026, 14:20 Hrs [IST] Artic ...
Pharmabiz

Karma Foundation strengthens animal welfare efforts through advanced veterinary care in India

Karma Foundation strengthens animal welfare efforts through advanced veterinary care in India: Our Bureau, Bengaluru Wednesday, February 11, 2026, 14:10 Hrs [IST] Karma Foundation ...
Pharmabiz

VectorY Therapeutics doses first participant in phase 1/2 PIONEER-ALS trial to evaluate VTx-002 in people with amyotrophic lateral sclerosis

VectorY Therapeutics doses first participant in phase 1/2 PIONEER-ALS trial to evaluate VTx-002 in people with amyotrophic lateral sclerosis: Amsterdam Wednesday, February 11, 202 ...
Pharmabiz

Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout: Stockholm Wednesday, February 11, 2026, 14:00 Hrs [IST] Swedish Or ...
Pharmabiz

Dr Bruce Levine to receive the Genome Valley Excellence Award at Bio Asia 2026

Dr Bruce Levine to receive the Genome Valley Excellence Award at Bio Asia 2026: Our Bureau, Mumbai Tuesday, February 10, 2026 ...
Pharmabiz

US FDA accepts and grants priority review status to Takeda’s oveporexton for the treatment of narcolepsy type 1

US FDA accepts and grants priority review status to Takeda’s oveporexton for the treatment of narcolepsy type 1: Osaka, Japan Wednesday, February 11, 2026, 12:00 Hrs [IST] Taked ...
Pharmabiz

Chugai Pharma and Araris Biotech ink license agreement for Araris' linker-payload ADC technology AraLinQ

Chugai Pharma and Araris Biotech ink license agreement for Araris' linker-payload ADC technology AraLinQ: Tokyo Wednesday, February 11, 2026, 11:00 Hrs [IST] Chugai Pharmaceutical ...
Pharmabiz

Sanofi’s rilzabrutinib receives US FDA breakthrough therapy & Japanese orphan drug designations to treat warm autoimmune haemolytic anaemia

Sanofi’s rilzabrutinib receives US FDA breakthrough therapy & Japanese orphan drug designations to treat warm autoimmune haemolytic anaemia: Paris Wednesday, February 11, 2026, ...
Pharmabiz

GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older

GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older: London, UK Wednesday, February 11, 2026, 09:00 Hrs [IST] GSK plc announced ...
Pharmabiz

Pharmexcil to hold Chintan Shivir on long-term strategic roadmap for pharma industry on Feb 21 in Ahmedabad

Pharmexcil to hold Chintan Shivir on long-term strategic roadmap for pharma industry on Feb 21 in Ahmedabad: Shardul Nautiyal, Mumbai Wednesday, February 11, 2026, 08:00 Hrs [IST] ...